4th Annual Gene Therapy Analytical Development Summit 2022
Evvnt Promotion / evvnt
Archiv
28.11.2022 - 01.12.2022 The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, USA
Time: 9:00 am to 6:00 pm
Kongressthemen
The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4th Annual Gene Therapy Analytical Development as an analytical scientist has never been so important.
The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4th Annual Gene Therapy Analytical Development as an analytical scientist has never been so important.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Hanson Wade
Anmerkungen
Speakers: Adebowale Shoroye, Scientist, Biogen, Alexander Wong, Principal Research Associate, Sanofi Genzyme, Andrea Hamilton, Associate Director, Quality Control, Gyroscope Therapeutics
Speakers: Adebowale Shoroye, Scientist, Biogen, Alexander Wong, Principal Research Associate, Sanofi Genzyme, Andrea Hamilton, Associate Director, Quality Control, Gyroscope Therapeutics
Anfragen und Anmeldung:
https://go.evvnt.com/1259027-2?pid=4832
Frau Emily Birt
Gesundheitsversorgung, Public Health
Sprache
Englisch
Englisch
Kongressgebühr
USD 2999.00 - USD 5995.00
USD 2999.00 - USD 5995.00
Teilnehmer erwartet
1000
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
